Next Article in Journal
A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10)
Previous Article in Journal
Exploring the Challenges of Lipid Nanoparticle Development: The In Vitro–In Vivo Correlation Gap
 
 
Article

Article Versions Notes

Vaccines 2025, 13(4), 340; https://doi.org/10.3390/vaccines13040340
Action Date Notes Link
article xml file uploaded 22 March 2025 09:48 CET Original file -
article xml uploaded. 22 March 2025 09:48 CET Update https://www.mdpi.com/2076-393X/13/4/340/xml
article pdf uploaded. 22 March 2025 09:48 CET Version of Record https://www.mdpi.com/2076-393X/13/4/340/pdf
article supplementary file uploaded. 22 March 2025 09:48 CET - https://www.mdpi.com/2076-393X/13/4/340#supplementary
article html file updated 22 March 2025 09:54 CET Original file https://www.mdpi.com/2076-393X/13/4/340/html
Back to TopTop